Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
Administrative Data Research Centre - Scotland, University of Edinburgh, Edinburgh, UK.
J Epidemiol Community Health. 2019 Jan;73(1):34-41. doi: 10.1136/jech-2018-210842. Epub 2018 Nov 8.
Older people experience poorer outcomes from colon cancer. We examined if treatment for colon cancer was related to age and if inequalities changed over time.
Data from the UK population-based Northern and Yorkshire Cancer Registry on 31 910 incident colon cancers (ICD10 C18) diagnosed between 1999-2010 were obtained. Likelihood of receipt of: (1) cancer-directed surgery, (2) chemotherapy in surgical patients, (3) chemotherapy in non-surgical patients by age, adjusting for sex, area deprivation, cancer stage, comorbidity and period of diagnosis, was examined.
Age-related inequalities in treatment exist after adjustment for confounding factors. Patients aged 60- 69, 70-79 and 80+ years were significantly less likely to receive surgery than those aged <60 years (multivariable ORs (95% CI) 0.84(0.74 to 0.95), 0.54(0.48 to 0.61) and 0.19(0.17 to 0.21), respectively). Age-related differences in receipt of surgery and adjuvant chemotherapy (but not chemotherapy in non-surgical patients) narrowed over time for the 'younger old' (aged <80 years) but did not diminish for the oldest patients.
Age inequality in treatment of colon cancer remains after adjustment for confounders, suggesting age remains a major factor in treatment decisions. Research is needed to better understand the cancer treatment decision-making process, and how to influence this, for older patients.
老年人的结肠癌治疗效果较差。我们研究了结肠癌的治疗是否与年龄有关,以及这种不平等是否随时间而变化。
我们从英国基于人群的北方和约克郡癌症登记处获取了 1999-2010 年间诊断的 31910 例结肠癌(ICD10 C18)的发病数据。根据年龄,调整了性别、地区贫困程度、癌症分期、合并症和诊断时期等因素,检查了接受以下治疗的可能性:(1)针对癌症的手术,(2)手术患者的化疗,(3)非手术患者的化疗。
在调整了混杂因素后,治疗方面存在与年龄相关的不平等现象。60-69 岁、70-79 岁和 80 岁以上的患者接受手术的可能性明显低于<60 岁的患者(多变量 OR(95%CI)分别为 0.84(0.74 至 0.95)、0.54(0.48 至 0.61)和 0.19(0.17 至 0.21))。随着时间的推移,“年轻的老年人”(<80 岁)在接受手术和辅助化疗方面的年龄差异(但非手术患者的化疗差异)缩小,但最年长的患者没有减少。
即使在调整了混杂因素后,结肠癌治疗方面的年龄不平等仍然存在,这表明年龄仍然是治疗决策的主要因素。需要研究如何更好地了解癌症治疗决策过程,并影响最年长患者的决策。